{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:01:01Z","timestamp":1791414061617,"version":"4.3.3"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejogrb.2018.03.026","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T17:58:21Z","timestamp":1521395901000},"page":"133-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Predictive factor for volume reduction of uterine fibroids after short-term use of ulipristal acetate"],"prefix":"10.1016","volume":"224","author":[{"given":"Bo Seong","family":"Yun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Ju","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Wook","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-La","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Sook","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Kyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Shin","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2018.03.026_bib0005","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.fertnstert.2007.01.093","article-title":"Etiology, symptomatology, and diagnosis of uterine myomas","volume":"87","author":"Parker","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1056\/NEJMe1114043","article-title":"Uterine fibroids and evidence-based medicine?not an oxymoron","volume":"366","author":"Stewart","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejogrb.2017.06.047","article-title":"Update on medical treatment of uterine fibroids","volume":"216","author":"Faustino","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0030","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0035","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.fertnstert.2014.10.038","article-title":"Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids","volume":"103","author":"Donnez","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0040","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","article-title":"CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial","volume":"111","author":"Levens","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0045","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2010.09.059","article-title":"Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study","volume":"95","author":"Nieman","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejogrb.2016.11.003","article-title":"Real world data of 1473 patients treated with ulipristal acetate for uterine fibroids: Premya study results","volume":"208","author":"Fernandez","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/er.2005-0001","article-title":"Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis","volume":"26","author":"Chwalisz","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5468\/ogs.2017.60.1.69","article-title":"Uterine fibroid shrinkage after short-term use of selective progesterone receptor modulator or gonadotropin-releasing hormone agonist","volume":"60","author":"Lee","year":"2017","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0065","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbrc.2015.10.145","article-title":"Differential expression of estrogen receptor \u03b1 and \u03b2 isoforms in multiple and solitary leiomyomas","volume":"468","author":"Shao","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0070","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/humupd\/dmv030","article-title":"Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth","volume":"21","author":"Commandeur","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejogrb.2014.05.029","article-title":"Long-term risk of fibroid recurrence after laparoscopic myomectomy","volume":"180","author":"Radosa","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Bio"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0080","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/humupd\/dmi002","article-title":"Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications","volume":"11","author":"Chabbert-Buffet","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0085","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/humupd\/dmu056","article-title":"Role of nuclear progesterone receptor isoforms in uterine pathophysiology","volume":"21","author":"Patel","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0090","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-0030-1251483","article-title":"Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth","volume":"28","author":"Yoshida","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0095","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.fertnstert.2015.04.024","article-title":"Increased progesterone receptor expression in uterine leiomyoma: correlation with age, number of leiomyomas, and clinical symptoms","volume":"104","author":"Tsigkou","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0100","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12325-012-0042-8","article-title":"Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids","volume":"29","author":"Talaulikar","year":"2012","journal-title":"Adv Ther"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0105","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.fertnstert.2016.06.012","article-title":"Role of ethnicity in treating uterine fibroids with ulipristal acetate","volume":"106","author":"Murji","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0110","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jmig.2017.02.025","article-title":"Does ulipristal acetate affect surgical experience at laparoscopic myomectomy","volume":"24","author":"Luketic","year":"2017","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0115","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.humpath.2010.11.003","article-title":"Distinguishing features of endometrial pathology after exposure to the progesterone receptor modulator mifepristone","volume":"42","author":"Fiscella","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0120","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PGP.0b013e318251035b","article-title":"Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate","volume":"31","author":"Williams","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ejogrb.2018.03.026_bib0125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejogrb.2017.04.042","article-title":"Endometrial changes during ulipristal acetate use: a systematic review","volume":"214","author":"De Milliano","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211518301246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211518301246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T19:29:01Z","timestamp":1721330941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211518301246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":25,"alternative-id":["S0301211518301246"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2018.03.026","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive factor for volume reduction of uterine fibroids after short-term use of ulipristal acetate","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2018.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}